drugset / Trial / NCT00104754

Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer

NCT00104754 ↗

Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as liposomal SN-38, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well liposomal SN-38 works in treating patients with small cell lung cancer.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject 7-ethyl-10-hydroxy Camptothecin Small molecule — Intravenous